Computational study of nanosized drug delivery from Cyclodextrins, crown ethers and hyaluronan in pharmaceutical formulations

Current Topics in Medicinal Chemistry

Volumn 15, Issue 18, 2015, Pages 1901-1913

  Torrens, Francisco ^a   Castellano, Gloria ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

Author keywords

Drug delivery system; Fractal dimension; Hydroxypropyl cyclodextrin; Inclusion complex; Medicine absorption; Medicine delivery; Metal hyaluronate; Mucosa

Indexed keywords

ADENOSINE; BETAMETHASONE; BUDESONIDE; CAFFEINE; CROWN ETHER DERIVATIVE; CYCLODEXTRIN; DICLOFENAC; DOXORUBICIN; HYALURONIC ACID; METRONIDAZOLE; MINOXIDIL; THEOPHYLLINE; CROWN ETHER; NANOMATERIAL;

ANTIMICROBIAL ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; COMPUTER MODEL; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EXPERIMENTAL DESIGN; GEOMETRY; MOLECULAR DYNAMICS; THERMODYNAMICS; CHEMISTRY; MEDICINAL CHEMISTRY; PARTICLE SIZE;

CHEMISTRY, PHARMACEUTICAL; CROWN ETHERS; CYCLODEXTRINS; DRUG DELIVERY SYSTEMS; HYALURONIC ACID; MOLECULAR STRUCTURE; NANOSTRUCTURES; PARTICLE SIZE;

EID: 84934757162     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150506145619     Document Type: Article

References (127)

1. Stella, V. J.; He, Q. Cyclodextrins. Toxicol. Pathol., 2008, 36, 30-42.
2. Davydov, D. R.; Davydova, N. Y.; Halpert J.R. Allosteric transi- tions in cytochrome P450eryF explored with pressure-perturbation spectroscopy, lifetime FRET, and a novel fluorescent substrate, Fluorol-7GA. Biochemistry, 2008, 47, 11348-11359.
3. Rusyniak, D. E.; Ootsuka, Y.; Blessing, W.W. When administered to rats in a cold environment, MDMA reduces brown adipose tissue thermogenesis and increases tail blood flow: Effects of pretreat-ment with 5-HT1A and dopamine D2 antagonists. Neuroscience, 2008, 154, 1619-1626.
4. Smith, R. J.; See, R. E.; Aston-Jones, G. Orexin/hypocretin signal- ing at the orexin 1 receptor regulates cue-elicited cocaine-seeking. Eur. J. Neurosci., 2009, 30, 493-503.
5. Chen S.; Wang, J. M.; Irwin, R. W.; Yao, J.; Liu, L.; Brinton, R.D. Allopregnanolone promotes regeneration and reduces (3-amyloid burden in a preclinical model of Alzheimer’s disease. PLoS ONE, 2011, 6(24293), 1-13.
6. Italia, J L.; Sharp A.; Carter, K. C; Warn, P.; Kumar, M.N.V.R. Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambi-some® or Fungizone™. PLoS ONE, 2011, 6(25744), 1-8.
7. Wang, Z.; Zuo, G.; Shi, X.-Y.; Zhang, J.; Fang, Q.; Chen, G. Progesterone administration modulates cortical TLR4/NF-KB signaling pathway after subarachnoid hemorrhage in male rats. Mediators Inflamm., 2011, 2011(848309), 1-9.
8. López-Nicolás, J. M.; Bru, R.; Sánchez-Ferrer, A.; García- Carmona, F. Use of soluble lipids for biochemical processes: Lino-leic acid-cyclodextrin inclusion complexes in aqueous solutions. Biochem. J., 1995, 308, 151-154.
9. Bru, R.; López-Nicolás, J. M.; García-Carmona, F. Aggregation of polyunsaturated fatty acids in the presence of cyclodextrins. Colloids Surf, A, 1995, 97, 263-269.
10. López-Nicolás, J. M.; Bru, R.; García-Carmona, F. Kinetic characteristics of the enzymatic conversion in presence of cyclodextrins: Study of the oxidation of polyunsaturated fatty acids by lipoxygenase. Biochim. Biophys. Acta, 1997, 1347, 140-150.
11. Becket, G.; Schep, L. J.; Tan, M.Y. Improvement of the in vitro disolution of praziquantel by complexation with o-, (3- and Y-cyclodextrins. Int. J. Pharm., 1999, 179, 65-71.
12. Sharghi, H.; Ebrahimpourmoghaddam, S. Unique fluorophores of lariat naphtho-aza-crown ethers. Helv. Chim. Acta, 2008, 91, 1363-1373.
13. Balazs, E. A. Ed., The Chemistry and Molecular Biology of the Intercellular Matrix; Academic: New York, 1970.
14. Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K.; Walter, P. Molecular Biology of the Cell; Garland: New York, 2002.
15. Laurent, T. C.; Fraser, J.R.E. Hyaluronan. FASEB J., 1992, 6, 2397-2404.
16. Goa, K. L.; Benfield, P. Hyalurinic-acid – A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound-healing. Drugs, 1994, 47, 536-566.
17. Zimmerman, E.; Geiger, B.; Addadi, L. Initial stages of cell-matrix adhesion can be mediated and modulated by cell-surface hyaluronan. Biophys. J., 2002, 82, 1848-1857.
18. Moulabbi, M.; Broch, H.; Rober, L.; Vasilescu, D. Quantum molecular modeling of hyaluronan. J. Mol. Struct. (THEOCHEM), 1997, 395, 477-508.
19. Morris, E. R.; Rees, D. A.; Welsh, E.J. Conformation and dynamic interactions in hyaluronate solutions. J. Mol. Biol., 1980, 138, 383-400.
20. Sipos, P.; Veber, M.; Burger, K.; Illes, J.; Machula, G. Hyaluro-nate–metal ion interactions: Correlations between viscosimetric, potentiometric, polarographic and electrophoretic data. Acta Chim. Hung. Models Chem., 1992, 129, 671-683.
21. Figueroa, N.; Nagy, B.; Chakrabarti, B. Cu2+–hyaluronic acid com-plex-spectrophotometric detection. Biochem. Biophys. Res. Com-mun., 1977, 74, 460-465.
22. Sterk, H.; Braun, M.; Schmut, O.; Feichtinger, H. Investigation of the hyaluronic acid–copper complex by N.M.R. spectroscopy. Carbohydr. Res., 1985, 145, 1-11.
23. Lapcik, L.; Dammer, C.; Valko, M. Hyaluronic acid–copper(ii) complexes-spectroscopic characterization. Colloid Polym. Sci., 1992, 201, 1049-1052.
24. Atkins, E. D.; Sheehan, J. K.; Phelps, C.F. Conformation of mucopolysaccharides-hyaluronates. Biochem. J., 1972, 128, 1255-263
25. Winter, W. T.; Arnott, S. Hyaluronic acid: The role of divalent cations in conformation and packing. J. Mol. Biol., 1977, 117, 761-784.
26. Sheehan, J. K.; Atkins, E. D. X-ray fiber diffraction study of con-formational-changes in hyaluronate induced in the presence of sodium, potassium and calcium cations. Int. J. Biol. Macromol., 1983, 5, 215-221
27. Mitra, A. K.; Raghunathan, S.; Sheehan, J. K.; Arnott, S. Hyaluronic-acid-molecular-conformations and interactions in the orthorhombic and tetragonal forms containing sinuous chains. J. Mol. Biol., 1983, 169, 829-859.
28. Eklund, R.; Widmalm, G. Molecular dynamics simulations of an oligosaccharide using a force field modified for carbohydrates. Carbohydr. Res., 2003, 338, 393-398.
29. Warshel, A.; Levitt, M. Theoretical studies of enzymic reactions: Dielectric, electrostatic and steric stabilization of the carbonium ion in the reaction of lysozyme. J. Mol. Biol., 1976, 103, 227-249.
30. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminatham, S.; Karplus, M. CHARMM: A program for macro-molecular energy, minimization, and dynamics calculations. J. Comput. Chem., 1983, 4, 187-217.
31. Becke, A. D. Density-functional exchange-energy approximation with correct asymptotic-behavior. Phys. Rev. A, 1988, 38, 3098-3100.
32. Lee, C. T.; Yang, W. T.; Parr, G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron-density. Phys. Rev. B, 1988, 37, 785-789.
33. MacKerell, A. D., Jr.; Bashford, D.; Bellott, M.; Dunbrack, R. L., Evanseck, J. D.; Field, M. J.; Fischer, S.; Gao, J.; Guo, H.; Ha, S.; Joseph-McCarthy, D.; Kuchnir, L.; Kuczera, K.; Lau, F. T. K.; Mattos, C.; Michnick, S.; Ngo, T.; Nguyen, D. T.; Prodhom, B.; Reiher, W. E.,; Roux, B.; Schlenkrich, M.; Smith, J. C.; Stote, R.; Straub, J.; Watanabe, M.; Wiórkiewicz-Kuczera, J.; Yin, D.; Karplus, M. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B, 1998, 102, 3586-3616.
34. Masgrau, L.; Roujeinikova, A.; Johannissen, L. O.; Hothi, P.; Bas-ran, J.; Ranaghan, K. E.; Mulholland, A. J.; Sutcliffe, M. J.; Scrut-ton, N. S.; Leys, D. Atomic description of an enzyme reaction dominated by proton tunneling. Science, 2006, 312, 237-241.
35. Zidar, J.; Tratar Pirc, E.; Hodoscek, M.; Bukonec, P. Copper(II) ion binding to cellular prion protein. J. Chem. Model., 2008, 48, 283-287.
36. Zhao, Y.; Truhlar, D. The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncova-lent interactions, excited states, and transition elements: Two new functionals and systematic testing of four M06-class functionals and 12 other functional. Theor. Chem. Acc., 2008, 120, 215-241.
37. Brooks, B. R.; Brooks, C. L.,; Mackerell, A. D.,; Nilsson, L.; Petrella, R. J.; Roux, B.; Won, Y.; Archontis, G.; Bartels, C.; Boresch, S.; Caflisch, A.; Caves, L.; Cui, Q.; Dinner, A. R.; Feig, M.; Fischer, M.; Gao, J.; Hodoscek, M.; Im, W.; Kuczera, K.; Laz-aridis, T.; Ma, J.; Ovchinnikov, V.; Paci, E.; Pastor, R. W.; Post, C. B.; Pu, J. Z.; Schaefer, M.; Tidor, B.; Venable, R. M.; Woodcock, H. L.; Wu, X.; Yang, W.; York, D. M.; Karplus, M. CHARMM: The biomolecular simulation program. J. Comput. Chem. 2009, 30, 1545-1614.
38. Siegbahn, P.E. The performance of hybrid DFT for mechanisms involving transition metal complexes in enzymes. J. Biol. Inorg. Chem., 2006, 11, 695-701.
39. Hofstetter, T. E.; Howder, C.; Berden, G.; Oomens, J.; Armentrout, P.B. Structural elucidation of biological and toxicological complexes: Investigation of monomeric and dimeric complexes of his-tidine with multiply charged transition metal (Zn and Cd) cations using IR action spectroscopy. J. Phys. Chem. B, 2011, 115, 12648-12661.
40. Remko, M.; Fitz, D.; Broer, R.; Rode, B.M. Effect of metal ions (Ni2+, Cu2+ and Zn2+) and water coordination on the structure of L-phenylalanine, L-tyrosine, L-tryptophan and their zwitterionic forms. J. Mol. Model., 2011, 17, 3117-3128.
41. Khodabandeh, M. H.; Hamid, R.; Zare, K.; Zahedi, M. A theoretical elucidation of coordination properties of histidine and lysine to Mn2+. Int. J. Mass Spectrom., 2012, 313, 47-57.
42. Minenkov, Y.; Singstad, Å.; Occhipinti, G.; Jensen, V.R. The accuracy of DFT-optimized geometries of functional transition metal compounds: A validation study of catalysts for olefin metathesis and other reactions in the homogeneous phase. Dalton Trans., 2012, 41, 5526-5541.
43. Heinegård, D.; Oldberg, Å. Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J., 1989, 3, 2042-2051.
44. Asane, G. S., Nirmal, S. A.; Rasal, K. B.; Naik, A. A.; Mahadik, M. S.; Rao, Y.M. Polymers for mucoadhesive drug delivery system: Current status. Drug Dev. Ind. Pharm., 2008, 34, 1246-1266.
45. Peppas, N. A.; Buri, P.A. Surface, interfacial and molecular aspects of bioadhesion on soft tissues. J. Control Release, 1985, 2, 257-275.
46. Gu, J. M.; Robinson, J. R.; Leung, S. H. Binding of acrylic polymers to mucin/epithelial surfaces: Structure–property relationships. Crit. Rev. Ther. Drug Carrier Syst., 1988, 5, 21-67.
47. Woodley, J. Bioadhesion: New possibilities for drug administration? Clin. Pharmacokinet., 2001, 40, 77-84.
48. Smart, J. D. The basics and underlying mechanisms of mucoadhe-sion. Adv. Drug Deliv. Rev., 2005, 57, 1556-1568.
49. Alemdar, A.; Güngör, N.; Ece, O. I.; Atici, O. The rheological properties and characterization of bentonite dispersions in the presence of non-ionic polymer PEG. J. Mater. Sci., 2005, 40, 171-177.
50. Pliszczak, D.; Bordes, C.; Bourgeois, S.; Marote, P.; Zahouani, H.; Tupin, S.; Pailler Mattei, C.; Lantéri, P. Mucoadhesion evaluation of polysaccharide gels for vaginal application by using rheological and indentation measurements. Colloids Surf. B, 2012, 92, 168-174.
51. Cullins, V. E.; Dominguez, L.; Guberski, T.; Secor, M. R.; Wysocki, S. J. Treating vaginitis. Nurse Practitioner, 1999, 24, 46-65.
52. Hainer, B. L.; Gibson, M. V. Vaginitis: Diagnosis and treatment. Am. Fam. Physician, 2011, 83, 807-815.
53. Otberg, N.; Finner, A. M.; Shapiro, J. Androgenic alopecia. Endo-crinol. Metab. Clin. N. Am., 2007, 36, 379-398.
54. Hasegawa, N.; Mori, M. Effect of powdered green tea and its caffeine content on lipogenesis and lipolysis in 3T3-L1 cell. J. Health Sci., 2000, 46, 153-155.
55. Lian, G.; Chen, L.; Han, L. An evaluation of mathematical models for predicting skin permeability. J. Pharm. Sci., 2008, 97, 584-598.
56. Belay, A. Some biochemical compounds in coffee beans and methods developed for their analysis. Int. J. Phys. Sci., 2011, 6, 6373-6378.
57. Fuhr, U.; Maier, A.; Keller, A.; Steinijans, V. W.; Sauter, R.; Staib, A.H. Lacking effects of grapefruit juice on theophylline pharma-cokinetics. Int. J. Clin. Pharmacol. Ther., 1995, 33, 311-314.
58. Fuhr, U.; Klittich, K.; Staib, A. H. Inhibitory effect of grapefruit juice and its bitter principal naringenin, on CYP1A2 dependent me- tabolism of caffeine in man. Br. J. Clin. Pharmacol., 1993, 35, 431-436.
59. Maish, W. A.; Hampton, E. M.; Whitsett, T. L.; Shepard, J. D.; Lovallo, W. R. Influence of grapefruit juice on caffeine pharma-cokinetics and pharmacodynamics. Pharmacology, 1996, 16, 1046-1052.
60. Chung, W. G.; Kang, J. H.; Lee, K. H.; Roh, H.-K.; Cha, Y.-N. Determination of flavin-containing monooxygenase (FMO) activity using human caffeine metabolism and differential inhibition of FMO activity with grapefruit juice. Clin. Pharmacol. Ther., 1997, 61, 225-225.
61. Ljungh, Å.; Wadström, T. Lactic acid bacteria as probiotics. Curr. Issues Intest. Microbiol., 2006, 7, 73-89.
62. Ljungh, Å.; Wadström, T., Eds. Lactobacillus Molecular Biology: From Genomics to Probiotics; Caister Academic: Norfolk, UK, 2009.
63. Turovskiy, Y.; Noll, K. S.; Chikindas, M. L. The aetiology of bacterial vaginosis. J. Appl. Microbiol., 2011, 110, 1105-1128.
64. Machado, A.; Jefferson, K. K.; Cerca, N. Interactions between Lactobacillus crispatus and bacterial vaginosis (BV)-associated bacterial species in initial attachment and biofilm formation. Int. J. Mol. Sci., 2013, 14, 12004-12012.
65. Zhou, Y.; Mihindukulasuriya, K. A.; Gao, H.; La Rosa, P. S.; Wylie, K. M.; Martin, J. C.; Kota, K.; Shannon, W. D.; Mitreva, M.; Sodergren, E.; Weinstock, G. M. Exploration of bacterial community classes in major human habitats. Genome Biol., 2014, 15(66), 1-30.
66. Yadav, A. K.; Mishra, P.; Mishra, A. K.; Mishra, P.; Jain, S.; Agrawal, G. P. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Nanomedicine, 2007, 3, 246-257.
67. Wang, F.; Garza, L. A.; Kang, S.; Varani, J.; Orringer, J. S.; Fisher, G. J.; Voorhees, J. J. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch. Dermatol., 2007, 143, 155-163.
68. Jawalekar, S.; Surve, V.; Bhutey, A. Urinary excretion of glycosa-minoglycans in patients with urolithiasis. Int. J. Biochem. Res. Rev., 2013, 3, 74-81.
69. Yagoda, M. R.; Gans, E.H. A nutritional supplement formulated with peptides, lipids, collagen and hyaluronic acid optimizes key aspects of physical appearance in nails, hair and skin. Nutr. Food Sci., 2014, S5(2), 1-6.
70. Torrens, F. Valence topological charge-transfer indices for dipole moments. Molecules, 2003, 8, 169-185.
71. Torrens, F. Valence topological charge-transfer indices for dipole moments: Percutaneous enhancers. Molecules, 2004, 9, 1222-1235.
72. Torrens, F. Fractal dimension of transdermal-delivery drug models. Leb. Sci. J., 2004, 5(1), 61-70.
73. Torrens, F.; Castellano, G. Fractal dimension of transdermal-delivery drug models: 4-Alkylanilines. J. Liq. Chromatogr. Relat. Technol., 2008, 31, 2337-2347.
74. Torrens, F. Calculations on cyclopyranoses as co-solvents of single-wall carbon nanotubes. Mol. Simul., 2005, 31, 107-114.
75. Torrens, F. Calculations on solvents and co-solvents of single-wall carbon nanotubes: Cyclopyranoses, Nanotechnology, 2005, 16, S181-S189.
76. Torrens, F. Calculations on solvents and co-solvents of single-wall carbon nanotubes: Cyclopyranoses, J. Mol. Struct. (THEOCHEM), 2005, 757, 183-191.
77. Torrens, F.; Castellano, G. (Co-)solvent selection for single-wall carbon nanotubes: Best solvents, acids, superacids and guest–host inclusion complexes, Nanoscale, 2011, 3, 2494-2510.
78. Castellano-Estornell, G.; Torrens-Zaragozá, F. Quantitative struc-ture–antioxidant activity models of isoflavonoids from Dalbergia parviflora. Nereis, in press.
79. Torrens, F.; Castellano, G.; Campos, A.; Abad, C. Binding of water-soluble, globular proteins to anionic model membranes. J. Mol. Struct., 2009, 924, 274-284.
80. Torrens, F.; Castellano, G. Comparative analysis of the electrostatics of the binding of cationic proteins to vesicles: Asymmetric location of anionic phospholipids. Anal. Chim. Acta, 2009, 654, 2-10.
81. Torrens, F.; Castellano, G. Binding of mono, bi and tridomain proteins to zwitterionic and anionic vesicles: Asymmetric location of anionic phospholipids in mixed zwitterionic/anionic vesicles and cooperative binding. J. Life Sci., 2011, 5, 167-181.
82. Torrens, F.; Castellano, G. Valence charge-transfer indices and binding of water-soluble, globular proteins to vesicles. Asia Pacific J. Life Sci., 2013, 5, 89-121.
83. Torrens, F.; Castellano, G. A tool for interrogation of macromo-lecular structure. J. Mater. Sci. Eng. B, 2014, 4(2), 55-63.
84. Torrens, F.; Castellano, G. Mucoadhesive polymer hyaluronan as biodegradable cationic/zwitterionic-drug delivery vehicle. ADMET DMPK, 2014, 2, 235-247.
85. Flory, P. J.; Rehner, J. Statistichal mechanics of cross-linked polymer networks. II. Swelling. J. Chem. Phys., 1943, 11, 521-526.
86. Flory, P. J. Principles of Polymer Chemistry; Cornell University: Ithaca, NY, 1953.
87. Treloar, R. G. The Physics of Rubber Elasticity; Oxford University: Oxford, 1958.
88. Peppas, N. A.; Merrill, E. W. Crosslinked poly(vinyl alcohol) hy-drogels as swollen elastic networks. J. Appl. Polym. Sci., 1977, 21, 1763-1770.
89. Katchalsky, A.; Michaeli, I. Polyelectrolyte gels in salt solution. J. Polym. Sci., 1955, 15, 69-86.
90. Ricka, J.; Tanaka, T. Swelling of ionic gels: Quantitative performance of the Donnan theory. Macromolecules, 1984, 17, 2916-2921.
91. Brannon-Peppas, L.; Peppas, N. A. Equilibrium swelling behavior of pH-sensitive hydrogels. Chem. Eng. Sci., 1991, 46, 715-722.
92. Torrens, F.; Ortí, E.; Sánchez-Marín, J. Vectorized TOPO program for the theoretical simulation of molecular shape. J. Chim. Phys. Phys.-Chim. Biol., 1991, 88, 2435-2441.
93. Meyer A. Y. Molecular mechanics and molecular shape. Part 1. Van der Waals descriptors of simple molecules. J. Chem. Soc., Perkin Trans. 2, 1985, 1985, 1161-1169.
94. Meyer, A. Y. Molecular mechanics and molecular shape. V. On the computation of the bare surface area of molecules. J. Comput. Chem., 1988, 9, 18-24.
95. Lee, B.; Richards, F.M. The interpretation of protein structures: Estimation of static accessibility. J. Mol. Biol., 1971, 55, 379-400.
96. Hermann, R.B. Theory of hydrophobic bonding. II. The correlation of hydrocarbon solubility in water with solvent cavity surface area. J. Phys. Chem., 1972, 76, 2754-2759.
97. Bondi, A. Van der Waals volumes and radii. J. Phys. Chem., 1964, 68, 441-451.
98. Wodak, S. J.; Janin, J. Analytical approximation to the accessible surface area of proteins. Proc. Natl. Acad. Sci. U. S. A., 1980, 77, 1736-1740.
99. Lewis, M.; Rees, D.C. Fractal surfaces of proteins. Science, 1985, 230, 1163-1165.
100. Torrens, F.; Sánchez-Marín, J.; Nebot-Gil, I. New dimension indices for the characterization of the solvent-accessible surface. J. Comput. Chem., 2001, 22, 477-487.
101. Torrens, F.; Rubio, M.; Sánchez-Marín, J. AMYR 2: A new version of a computer program for pair potential calculation of molecular associations. Comput. Phys. Commun., 1998, 115, 87-89.
102. Pascual-Ahuir, J. L.; Silla, E.; Tomasi, J.; Bonaccorsi, R. Electrostatic interaction of a solute with a continuum. Improved description of the cavity and of the surface cavity bound charge distribution. J. Comput. Chem., 1987, 8, 778-787.
103. Terryn, B.; Barriol, J. On the evaluation of the usual quantities or coefficients related to the shape of a molecule approximated on the basis of the van der Waals radii. J. Chim. Phys. Phys.-Chim. Biol., 1981, 78, 207-212.
104. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. AM1: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc., 1985, 107, 3902-3909.
105. Andersson, T.; Westman, G.; Stenhagen, G.; Sundahl, M.; Wenner-ström, O. A gas phase container for C60; a γ-cyclodextrin dimer. Tetrahedron Lett., 1995, 36, 597-600.
106. Star, A.; Steuerman, D. W.; Heath, J. R.; Stoddart, J.F. Starched carbon nanotubes. Angew. Chem., Int. Ed., 2002, 41, 2508-2512.
107. Davis, J. J.; Green, M. L. H.; Hill, H. A. O.; Leung, Y. C.; Sadler, P. J.; Sloan, J.; Xavier, A. V.; Tsang, S. C. The immobilization of proteins in carbon nanotubes. Inorg. Chim. Acta, 1998, 272, 261-266.
108. Schanté, C. E.; Zuber, G.; Herlin, C.; Vandamme, T.F. Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohydr. Polym., 2011, 85, 469-489.
109. Schanté, C. E.; Zuber, G.; Herlin, C.; Vandamme, T. F. Improvement of hyaluronic acid enzymatic stability by the grating of amino-acids. Carbohydr. Polym., 2012, 87, 2211-2216.
110. Peppas, N. A.; Bures, P.; Leobandung, W.; Ichikawa, H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm., 2000, 50, 27-46.
111. Prestwich, G. D.; Kuo, J. W. Chemically-modified HA for therapy and regenerative medicine. Curr. Pharm. Biotechnol., 2008, 9, 242-245.
112. Prestwich, G. D.; Marecak, D. M.; Marecek, J. F.; Vercruysse, K. P.; Ziebell, M.R. Controlled chemical modification of hyaluronic acid: Synthesis, applications, and biodegradation of hydrazide derivatives. J. Controlled Release, 1998, 53, 93-103.
113. Burdick, J. A.; Prestwich, G. D. Hyaluronic acid hydrogels for biomedical applications. Adv. Mater., 2011, 23, H41-H56.
114. Son, G. M.; Kim, H. Y.; Ryu, J. H.; Chu, C. W.; Kang, D. H.; Park, S. B.; Jeong, Y.-I. Self-assembled polymeric micelles based on hyaluronic acid-g-poly(D,L-lactide-co-glycolide) copolymer for tumor targeting. Int. J. Mol. Sci. 2014, 15, 16057-16068.
115. Xu, X.; Jha, A. K.; Harrington, D. A.; Farach-Carson, M. C.; Jia, X. Hyaluronic acid-based hydrogels: From a natural polysaccharide to complex networks. Soft Matter, 2012, 8, 3280-3294.
116. Al-Abdulla, S. A. A.; Al-Assady, N. A. H.; Syyah, S. G. Preparation and in vitro evaluation of mucoadhesive films containing met-ronidazole. J. Thi-Qar Sci., 2012, 3, 129-140.
117. Polexe, R. C.; Delair, T. Elaboration of stable and antibody func-tionalized positively charged colloids by polyelectrolyte complexa-tion between chitosan and hyaluronic acid. Molecules, 2013, 18, 8563-8578.
118. Abdel-Mohsen, A. M.; Hrdina, R.; Burgert, L.; Krylová, G.; Abdel-Rahman, R. M.; Krejçová, A.; Steinhart, M.; Beneß, L. Green synthesis of hyaluronan fibers with silver nanoparticles. Carbohydr. Polym., 2012, 89, 411-422.
119. Chudobova, D.; Nejdl, L.; Gamulec, J.; Krystofova, O.; Merlos Rodrigo, M. A.; Kynicky, J.; Ruttkay-Nedecky, B.; Kopel, P.; Ba-bula, P.; Adam, V.; Kizek, R. Complexes of silver(I) ions and silver phosphate nanoparticles with hyaluronic acid and/or chitosan as promising antimicrobial agents for vascular grafts. Int. J. Mol. Sci., 2013, 14, 13592-13614.
120. Potts, R. O.; Guy, R. H. Predicting skin permeability. Pharm. Res., 1992, 9, 663-669.
121. Freeman, C. D.; Klutman, N. E.; Lamp, K. C. Metronidazole. Drugs, 1997, 54, 679-708.
122. Löfmark, S.; Edlund, C.; Nord, C. E. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin. Infect. Dis., 2010, 50, S16-S23.
123. Bayraktar, H.; Akal, E.; Sarper, O.; Varnali, T. Modeling glycosa-minoglycans–hyaluronan, chondroitin, chondroitin sulfate A, chon-droitin sulfate C and keratan sulfate. J. Mol. Struct. (THEOCHEM), 2004, 683, 121-132.
124. Tratar Pirc, E.; Arcon, I.; Bukovec, P.; Kodre, A. Preparation and characterisation of copper(II) hyaluronate. Carbohydr. Res., 2000, 324, 275-282.
125. Tratar Pirc, E.; Arcon, I.; Kodre, A.; Bukovec, P. Metal-ion environment in solid Mn(II), Co(II) and Ni(II) hyaluronates. Carbo-hydr. Res., 2004, 339, 2549-2554.
126. Tratar Pirc, E.; Zidar, J.; Bukovec, P.; Hodoscek, M. Molecular modeling of cobalt(II) hyaluronate. Carbohydr. Res., 2005, 340, 2064-2069.
127. Tratar Pirc, E.; Zidar, J.; Bukovec, P. A computational study of calcium(II) and copper(II) ion binding to the hyaluronate molecule. Int. J. Mol. Sci., 2012, 13, 12036-12045.